0001562180-18-000334.txt : 20180117 0001562180-18-000334.hdr.sgml : 20180117 20180117170001 ACCESSION NUMBER: 0001562180-18-000334 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180117 FILED AS OF DATE: 20180117 DATE AS OF CHANGE: 20180117 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VAN LUNSEN GIL J CENTRAL INDEX KEY: 0001205014 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-16633 FILM NUMBER: 18532079 MAIL ADDRESS: STREET 1: C/O HOGAN & HARTSON LLP STREET 2: 1470 WALNUT STREET SUITE 200 CITY: BOULDER STATE: CO ZIP: 80302 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARRAY BIOPHARMA INC CENTRAL INDEX KEY: 0001100412 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 841460811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 BUSINESS PHONE: 3033816600 MAIL ADDRESS: STREET 1: 3200 WALNUT STREET CITY: BOULDER STATE: CO ZIP: 80301 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2018-01-17 false 0001100412 ARRAY BIOPHARMA INC ARRY 0001205014 VAN LUNSEN GIL J C/O ARRAY BIOPHARMA INC. 3200 WALNUT STREET BOULDER CO 80301 true false false false Common Stock 2018-01-17 4 M false 15000.00 1.74 A 34297.00 D Common Stock 2018-01-17 4 M false 6500.00 2.46 A 40797.00 D Common Stock 2018-01-17 4 S false 21500.00 12.94 D 19297.00 D Stock Option (Right to Buy) 2.46 2018-01-17 4 M false 6500.00 0.00 D 2012-10-26 2021-10-26 Common Stock 6500.00 13500.00 D Stock Option (Right to Buy) 1.74 2018-01-17 4 M false 15000.00 0.00 D 2019-10-29 Common Stock 15000.00 0.00 D These trades were made pursuant to a Rule 10b5-1 trading plan. Options vested in three equal annual installments commencing November 1, 2009 and ending November 1, 2011. Jason Haddock, attorney in fact for Reporting Person 2018-01-17